Prognostic Factors Associated With Disease Progression and Overall Survival in Patients With Myelodysplastic Syndromes Treated With Decitabine

Decitabine improves overall survival (OS) and reduces risk of progression to acute myeloid leukemia (AML) in myelodysplastic syndromes (MDS). In this retrospective analysis of data from 2 decitabine studies (n = 162), hemoglobin level > 10 g/dL, platelet count > 50 × 10(3)/μL, and lack of chro...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, O'Brien, Susan, Fullmer, Amber, Cortes, Jorge E., Wierda, William, Kantarjian, Hagop
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2012
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098775/
https://ncbi.nlm.nih.gov/pubmed/23260600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2012.11.001
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन